SAN MATEO, Calif., Nov. 30 /PRNewswire/ -- Epocrates, Inc. announced today the promotion of Jeff Tangney to Senior Vice President of Sales & Client Service. Tangney will manage all Epocrates business units including health services, market research, continuing medical education, pharmaceutical, and group sales. Previously, Tangney was Epocrates’ Vice President of Subscriber Marketing and Product Development.
“Jeff has led Epocrates in its tremendous growth over the past year,” said Kirk Loevner, CEO of Epocrates. “He has an in-depth understanding of our products, the respect of our sales teams, and a unique rapport with our customers. Most importantly, he brings a creative and pragmatic approach to developing new products that serve our customers’ complex needs. He is the right person to lead Epocrates’ next phase of growth.”
Epocrates received the 2004 Award for Business Development Strategy Leadership from the emerging high-technology analyst firm Frost & Sullivan. Both Epocrates’ direct sales through its web site and its partnerships with wireless providers were cited as key drivers of the company’s success. Tangney led these initiatives as VP of subscriber marketing and product development.
Tangney co-founded Epocrates in 1998 with fellow Stanford graduate Richard Fiedotin, MD. Prior to Epocrates, Tangney was a manager at the consulting firm ZS Associates, where he provided marketing strategies to pharmaceutical clients. Tangney graduated from the University of Wisconsin with a B.S. in Economics, and earned an M.B.A. from Stanford University’s Graduate School of Business.
About Epocrates, Inc.
San Mateo, CA-based Epocrates Inc. is the leading provider of clinical information at the point of care, with more than 420,000 health care professionals, including over 25 percent of U.S. physicians, actively using its products. Epocrates’ product offering is led by the Epocrates(R) Essentials mobile clinical reference suite featuring all of the key decision support applications-drugs, diseases, and diagnostics -- required for today’s health care professional. The Epocrates Rx(R) and Epocrates Rx Pro(TM) drug reference products are the most widely used in the industry, by individual clinicians and by medical groups, hospitals, universities and medical libraries. Epocrates also provides formulary information from health plans, hospitals, Medicaid agencies and pharmacy benefit management (PBM) companies that represent over 95 million individuals, and messaging and market research services. For more information, visit http://www.epocrates.com/.
Epocrates, Inc.
CONTACT: Katherine Thornberry of Epocrates Public Relations,+1-650-227-1713, or kthornberry@epocrates.com
Web site: http://www.epocrates.com/